Last reviewed · How we verify
Sanaria® PfSPZ Vaccine
Sanaria® PfSPZ Vaccine is a Biologic drug developed by Sanaria Inc.. It is currently in Phase 2 development.
At a glance
| Generic name | Sanaria® PfSPZ Vaccine |
|---|---|
| Sponsor | Sanaria Inc. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso (PHASE1)
- Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults (PHASE2)
- Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria (PHASE2)
- PfSPZ Vaccine Trial in Malian Children (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sanaria® PfSPZ Vaccine CI brief — competitive landscape report
- Sanaria® PfSPZ Vaccine updates RSS · CI watch RSS
- Sanaria Inc. portfolio CI
Frequently asked questions about Sanaria® PfSPZ Vaccine
What is Sanaria® PfSPZ Vaccine?
Sanaria® PfSPZ Vaccine is a Biologic drug developed by Sanaria Inc..
Who makes Sanaria® PfSPZ Vaccine?
Sanaria® PfSPZ Vaccine is developed by Sanaria Inc. (see full Sanaria Inc. pipeline at /company/sanaria-inc).
What development phase is Sanaria® PfSPZ Vaccine in?
Sanaria® PfSPZ Vaccine is in Phase 2.
Related
- Manufacturer: Sanaria Inc. — full pipeline
- Compare: Sanaria® PfSPZ Vaccine vs similar drugs
- Pricing: Sanaria® PfSPZ Vaccine cost, discount & access